Delayed hepatic necrosis in a cystic fibrosis patient taking Elexacaftor/Tezacaftor/Ivacaftor (Kaftrio).

Salehi, Mahan; Iqbal, Mubashar; Dube, Asha; AlJoudeh, Amer; Edenborough, Frank

Salehi, Mahan; Iqbal, Mubashar; Dube, Asha; AlJoudeh, Amer; Edenborough, Frank.

Afiliación

Salehi M; Sheffield Teaching Hospitals, Adult Cystic Fibrosis Centre, Sheffield, UK.
Iqbal M; Sheffield Teaching Hospitals, Adult Cystic Fibrosis Centre, Sheffield, UK.
Dube A; Sheffield Teaching Hospitals, Department of Histopathology, Sheffield, UK.
AlJoudeh A; Sheffield Teaching Hospitals, Department of Gastroenterology and Hepatology, Sheffield, UK.
Edenborough F; Sheffield Teaching Hospitals, Adult Cystic Fibrosis Centre, Sheffield, UK.

Respir Med Case Rep ; 34: 101553, 2021.

Article en En | MEDLINE | ID: mdl-34815934

Palabras clave

ALP, Alkaline Phosphatase; ALT, Alanine Transaminase; AST, Aspartate Transaminase; Adverse effect; CF, Cystic Fibrosis; CFTR modulators; CFTRm, Transmembrane Regulator Protein Modulator; CMV, Cytomegalovirus; EBV, Epstein-Barr Virus; FEV1, Forced Expiratory Volume; GGT, Gamma-Glutamyl Transferase; Hepatic necrosis; Liver injury; Severe transaminitis; VZV, Varicella-Zoster Virus

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Respir Med Case Rep Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google